Viral Infection

WASHINGTON, D.C., June 5, 2026 Altesa BioSciences has unveiled encouraging new Phase 2 clinical findings demonstrating that vapendavir, its...

SCHLIEREN / ZURICH, Switzerland, June 5, 2026 Memo Therapeutics AG announced additional positive analyses from its Phase II SAFE...

SAN DIEGO, June 1, 2026 Ansun Biopharma has announced a significant clinical development milestone after an independent Data Monitoring...